REGN
Regeneron Pharmaceuticals, Inc.
Healthcare · NASDAQ · Market cap $82.3bn
$790.74
as of 16 Oct 2026, 8% below its 52-week high
Whether REGN’s profit and cash have covered its dividend, and how stretched its balance sheet is.
Cover today
- Earnings cover
- 11×Pays 9% of earnings
- Cash cover
- 9.3×Free cash flow over dividends paid
Loading dividend safety
See the Risk signals on the Scores tab
This page shows history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.